Explore the Global Procalcitonin (PCT) Assay Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Procalcitonin (PCT) Assay Market

Key Insight

Procalcitonin (PCT) assay sales will rise through 2036, driven by serum at 34.2% of the sample type segment in 2026. The market was valued at USD 316.40 million in 2025 and is expected to be worth USD 613.21 million by 2036, creating an incremental opportunity of USD 277.19 million.

May 27, 2026

Anurag Sharma

250 Pages

Cite this Report

Procalcitonin (PCT) Assay Market

https://www.futuremarketinsights.com/reports/procalcitonin-assay-market

License

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Boditech Med Inc
DRG Instruments GmbH
Danaher Corporation (Beckman Coulter)
DiaSorin S.p.A
Hoffmann-La Roche
Sichuan Maccura Biotechnology Co. Ltd
Siemens
Snibe Diagnostic
Thermo Fisher Scientific Inc.
Vazyme Biotech Co. Ltd
Wondfo Biotech Co. Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Procalcitonin (PCT) Assay Market

Key Players

Similar Industry Reports